SHA:600267

2 stories mentioning SHA:600267Updated just now

Every FINWIRES story that references SHA:600267, newest first.

Zhejiang Hisun Pharmaceutical Gets Approval for Cytomegalovirus Medication

China's drug regulator approved Zhejiang Hisun Pharmaceutical's (SHA:600267) letermovir antiviral active ingredient, according to a Tuesday filing with the Shanghai bourse.The drug is indicated for cytomegalovirus prevention and cure in adults and children weighing 6 kilograms or more.

SHA:600267

Asia39d ago

Hisun Pharmaceutical Clinches NMPA Drug Registration for Prostate Cancer Treatment

Zhejiang Hisun Pharmaceutical (SHA:600267) received a drug registration certificate from China's National Medical Products Administration for its apalutamide tablets, according to a Friday disclosure on the Shanghai bourse.The drug is used to treat prostate cancer.

SHA:600267

Track with the FINWIRES app suite

FolioX

Track SHA:600267 in your portfolio

WheelAI

Analyze SHA:600267 options with the wheel strategy

StockInsider

See market sentiment on SHA:600267